NEW YORK (GenomeWeb) – Danaher said Thursday that its first quarter sales grew 15 percent year over year.

For the three months ended April 1, the Washington-based conglomerate posted sales of $5.39 billion, up from $4.69 billion in the year-ago quarter, and beating the consensus Wall Street estimate of $5.33 billion.

Overall core sales improved by under 1 percent year over year, with acquisitions adding 16.5 percent to revenue growth and currency effects dampening results by 2 percent, the company said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.

Nov
15
Sponsored by
Twist Bioscience

This webinar will discuss how Amyris, a biotechnology company that develops renewable products for a broad range of applications and industries, uses large-scale microbial engineering to support its manufacturing processes.